Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer. - Wikidata - wikimedia - TriplyDB

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

http://www.wikidata.org/entity/Q34670947

about

Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer.Chemotherapy for advanced gastric cancer.The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer.Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro.

P2860

Q26798400-0DBC712D-0A79-4D48-B2C9-17CA627B8B1F Q34608899-062397FA-4244-49EA-A15B-17D7B82F4B55 Q38604012-11BFA8D6-A886-4BEB-ACF9-A9CBBF13F551 Q38941416-550F1C68-4CB8-49CC-A288-408A981E689C Q44441494-8B2ADF95-43BE-48EF-B0F6-B0EE1E6541C4 Q47402625-3DECB4B2-98A7-4A21-B772-2BDE5BB360CD Q53749471-B0280EB3-2F35-4C42-A256-B314DDF45836

P2860

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

http://www.wikidata.org/entity/Q34670947

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@ast

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@en

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@nl

type

label

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@ast

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@en

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@nl

prefLabel

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@ast

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@en

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@nl

P1433

Q34670947-A6EEF157-E6ED-4427-BC91-3B3BCDBDB1E8

P1476

Q34670947-A3E006CF-3BD1-4942-959E-98851630FB59

P2093

Q34670947-1A44F9F5-7C3C-4D6C-8707-8979A0FEC104

Q34670947-2DFC8B3E-9AFE-47DA-B949-684AADD510B9

Q34670947-3BBF61E6-DB02-45E4-978C-6B2534C58603

Q34670947-49DF214B-594C-4658-A6AD-AD8375C7D91D

Q34670947-58974FEA-C01F-4E65-993F-33D36F11311B

Q34670947-5E41EC33-7A26-4891-B3EC-350371CC7981

Q34670947-93D180C4-FB5B-4C8A-B0A0-4B9A444BDA37

P2860

Q34670947-14FDE150-5164-4828-87CB-1D6C247011D0

Q34670947-2690DA5D-1C0A-4030-BDAC-AA0D29AC0D2B

Q34670947-2EF5E119-EE15-409C-AECA-8449E4689454

Q34670947-31DAA1BB-F396-4DE4-8A3C-C83C21A90A83

Q34670947-3E3DFC0F-C184-46F9-9F43-5F7C6A5009C8

Q34670947-3E7DF2E2-70C4-46BF-B7F3-D69397A6F139

Q34670947-3F14AA24-700A-4C57-A532-49F52E539EA5

Q34670947-462D62BB-1732-4D43-B44D-869AB7911E05

Q34670947-49EA48EE-1C24-46FA-9B2F-F65C7924D8C8

Q34670947-5402C95D-7E8A-40D0-9F87-BC36F7D7CDED

P304

Q34670947-2FACAE0C-DF4B-4DC5-A13E-87A398D93C00

P31

Q34670947-344417A8-8CE8-40E6-9A7D-27C53591A0CA

P356

Q34670947-C93B0014-A5C7-4868-A3BF-27128AE160F1

P407

Q34670947-3A9EB82F-4025-4B00-A287-F83FAC366AE1

P433

Q34670947-A4803B47-D617-4A48-A5AF-2408A0B1D9D5

P478

Q34670947-78EBDD25-914F-4B81-B7FB-C9156581B1AB

P577

Q34670947-4C43168D-8E07-4C85-B0CF-8F41C23877A6

P5875

Q34670947-32E1CBE2-704C-4EE0-B2AF-83268E637BD6

P698

Q34670947-323D2A8C-2FF1-4064-B3D3-548F843F2FA6

P932

Q34670947-BE334473-6467-488B-9A4F-5BB8D3475BE2

P356

WJG.V17.I8.1082

P1433

World Journal of Gastroenterology

P1476

Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.

@en

P2093

Chang-Ping Wu

http://www.w3.org/2001/XMLSchema#string

Han-Ze Zhang

http://www.w3.org/2001/XMLSchema#string

Hua Shen

http://www.w3.org/2001/XMLSchema#string

Jing-Ting Jiang

http://www.w3.org/2001/XMLSchema#string

Xiao Zheng

http://www.w3.org/2001/XMLSchema#string

Xiao-Dong Li

http://www.w3.org/2001/XMLSchema#string

Yong-Qian Shu

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer.

Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.

Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic gastric cancer (MGC).

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

P304

1082-1087

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V17.I8.1082

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50907881

http://www.w3.org/2001/XMLSchema#string

P698

21448363

http://www.w3.org/2001/XMLSchema#string

P932

3057154

http://www.w3.org/2001/XMLSchema#string